Segment Information

6 Months Ended

Jun. 30, 2019

Segment Reporting [Abstract]

Segment Information

(11)        Segment Information

The Company has five reportable segments which include: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Fluorine Products, and Radiological Services. Information regarding the operations and assets of these reportable business segments is contained in the following table:

	Three months ended June 30,				Six months ended June 30,
Sale of Product	2019		2018		2019		2018
Radiochemical Products	$	774,107	$	602,344	$	1,237,339	$	1,185,885
Cobalt Products		213,239		324,768		589,328		652,546
Nuclear Medicine Standards		930,696		962,674		2,031,618		1,964,787
Radiological Services		217,797		502,520		805,406		1,390,114
Fluorine Products		—		—		—		—
Total Segments		2,135,839		2,392,306		4,663,691		5,193,332
Corporate revenue		—		—		—
Total Consolidated	$	2,135,839	$	2,392,306	$	4,663,691	$	5,193,332

	Three months ended June 30,				Six months ended June 30,
Depreciation and Amortization	2019		2018		2019		2018
Radiochemical Products	$	9,269	$	6,046	$	18,086	$	11,060
Cobalt Products		1,022		753		2,102		4,796
Nuclear Medicine Standards		15,673		16,530		31,292		34,468
Radiological Services		8,636		11,918		17,272		23,957
Fluorine Products		30,807		30,725		56,902		56,820
Total Segments		65,408		65,971		125,654		131,101
Corporate depreciation and amortization		53		141		4,791		4,985
Total Consolidated	$	65,461	$	66,112	$	130,445	$	136,086

	Three months ended June 30,						Six months ended June 30,
Segment Income (Loss)	2019			2018			2019			2018
Radiochemical Products	$	252,946		$	103,037		$	349,002		$	143,557
Cobalt Products		122,252			93,113			315,122			277,905
Nuclear Medicine Standards		111,921			165,294			328,743			389,236
Radiological Services		(901,234	)		164,441			(589,955	)		566,453
Fluorine Products		(39,927	)		(31,613	)		(77,422	)		(62,912	)
Total Segments		(454,042	)		494,273			325,490			1,314,239
Corporate loss		(703,152	)		(826,552	)		(1,534,641	)		(1,612,114	)
Net Income (Loss)	$	(1,157,194	)	$	(332,279	)	$	(1,209,151	)	$	(297,875	)

	Three months ended June 30,				Six months ended June 30,
Expenditures for Segment Assets	2019		2018		2019		2018
Radiochemical Products	$	14,844	$	—	$	14,845	$	—
Cobalt Products		—		—		3,493		—
Nuclear Medicine Standards		4,950		3,914		4,950		22,062
Radiological Services		—		39,354		—		39,354
Fluorine Products		—		—		1,589		1,560
Total Segments		19,794		43,268		24,877		62,976
Corporate purchases		—		—		—		—
Total Consolidated	$	19,794	$	43,268	$	24,877	$	62,976

	June 30		December 31,
Segment Assets	2019		2018
Radiochemical Products	$	325,151	$	344,994
Cobalt Products		3,033,304		2,611,939
Nuclear Medicine Standards		2,102,076		2,113,960
Radiological Services		800,523		281,077
Fluorine Products		5,534,739		5,590,053
Total Segments		11,795,793		10,942,023
Corporate assets		2,501,983		2,048,053
Total Consolidated	$	14,297,776	$	12,990,076